Revenue, last quarter
$28.4M
+8% vs same quarter last year
Net income
−$1.4M
+95.4% vs same quarter last year
EPS, diluted
-
Operating cash flow
$3.9M
+79.4% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $103.1M | - |
| FY24 | $86.7M | - |
| FY23 | $65M | - |
| FY22 | $45.8M | −$7.9M |
| FY21 | $24.1M | −$7.9M |
| FY20 | $15.6M | −$4.4M |
| FY19 | $11.8M | −$2.8M |
| FY18 | $5.8M | −$600.6K |
| FY17 | $6.3M | $331.3K |
| FY16 | $5.5M | −$415.7K |
| FY15 | $3.4M | −$1.3M |
| FY14 | $2.6M | −$2.3M |
| FY13 | $1.7M | −$4.1M |
| FY12 | $1.2M | −$1.8M |
| FY11 | $2.2M | −$12.7M |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 92.7% | 7.1% | - |
| FY24 | 90.6% | 1.5% | - |
| FY23 | 87.9% | −6.5% | - |
| FY22 | 86.1% | −27.3% | −17.3% |
| FY21 | 90.4% | −30.6% | −32.8% |
| FY20 | 89.6% | −32.3% | −28.5% |
| FY19 | 89.7% | −23.3% | −23.9% |
| FY18 | 91.3% | −8.6% | −10.3% |
| FY17 | 87.2% | 1.9% | 5.3% |
| FY16 | 82.9% | −4.9% | −7.5% |
| FY15 | 73.5% | −28.6% | −39.8% |
| FY14 | 69.5% | - | −86.5% |
| FY13 | 54.1% | - | −240.3% |
| FY12 | 32% | - | −157.2% |
| FY11 | 63.8% | −226.9% | −576.6% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | $2.2M |
| FY24 | −$229.6K |
| FY23 | −$3.5M |
| FY22 | −$5.7M |
| FY21 | −$5M |
| FY20 | −$4.6M |
| FY19 | −$2.4M |
| FY18 | $268.7K |
| FY17 | −$183.8K |
| FY16 | $406.2K |
| FY15 | −$1.2M |
| FY14 | −$1.7M |
| FY13 | −$1.9M |
| FY12 | - |
| FY11 | - |
- Sanara MedTech
- Healthcare median
Show the numbers
| Year | Sanara MedTech | Healthcare median |
|---|---|---|
| FY25 | - | −30.6% |
| FY24 | - | −47% |
| FY23 | - | −58% |
| FY22 | −17.3% | −80.4% |
| FY21 | −32.8% | −71.8% |
| FY20 | −28.5% | −62.2% |
| FY19 | −23.9% | −46.2% |
| FY18 | −10.3% | −49.6% |
| FY17 | 5.3% | −45.9% |
| FY16 | −7.5% | −36% |
| FY15 | −39.8% | −37.8% |
| FY14 | −86.5% | −35.5% |
| FY13 | −240.3% | −37.1% |
| FY12 | −157.2% | −29.1% |
| FY11 | −576.6% | −27.9% |